Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 14/20 | 0.47 |
| ▸ | CDC25B | P30305 | 13/20 | 0.47 |
| ▸ | PTPN2 | P17706 | 7/20 | 0.47 |
| ▸ | CDC25A | P30304 | 4/20 | 0.47 |
| ▸ | PTPN6 | P29350 | 3/20 | 0.47 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.45 |
| ▸ | MDM4 | O15151 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.45 |
| ▸ | BCHE | P06276 | 2/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | NT5E | P21589 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30980693 | 0.84 | PTPN1 (0.47) | PTPN1CDC25BPTPN2CDC25APTPN6 | |
| SCHEMBL30980723 | 0.81 | TP53 (0.45) | PTPN1CDC25BPTPN2CDC25APTPN6 | |
| SCHEMBL30980528 | 0.78 | TP53 (0.41) | PTPN1CDC25BPTPN2CDC25APTPN6 | |
| SCHEMBL30980750 | 0.75 | PTPN1 (0.47) | PTPN1CDC25BPTPN2CDC25APTPN6 | |
| SCHEMBL30980588 | 0.74 | NT5E (0.49) | PTPN1CDC25BPTPN2CDC25APTPN6 | |
| SCHEMBL24997002 | 0.73 | TACR1 (0.43) | PTPN1CDC25BPTPN2CDC25APTPN6 | |
| SCHEMBL15514995 | 0.71 | PTPN1 (0.55) | PTPN1CDC25BPTPN2CDC25APTPN6 | |
| SCHEMBL30980574 | 0.70 | HRAS (0.37) | — | |
| SCHEMBL12612570 | 0.70 | PTPN1 (0.50) | PTPN1CDC25BPTPN2CDC25APTPN6 | |
| SCHEMBL14001397 | 0.70 | PTPN1 (0.50) | PTPN1CDC25BPTPN2CDC25APTPN6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4651901-A1 | CYCLING LYSOSOMAL TARGETING ANTIBODY CONJUGATES | Lycia Therapeutics, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| EP-4651902-A2 | ASGPR BINDING COMPOUNDS AND CONJUGATES | Lycia Therapeutics, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| WO-2024155747-A2 | ASGPR BINDING COMPOUNDS AND CONJUGATES | LYCIA THERAPEUTICS, INC. (US) | 2024-07-25 | — | — | WO | disclosed |